Monopar Therapeutics short interest in 2024
In 2024, Monopar Therapeutics's disclosed short interest ran from 0.62% of shares outstanding on 12 Jan 2024 to 0.69% on 31 Dec 2024, a change of +0.07 percentage points. The year's high was 1.36% on 31 Oct 2024 and its low 0.34% on 15 Jul 2024, averaging 0.67% across 14 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.94 days on 15 Feb 2024. Full history: Monopar Therapeutics.
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 0.62% (12 Jan 2024)
- End of year
- 0.69% (31 Dec 2024)
- Change
- +0.07 pp
- High
- 1.36% (31 Oct 2024)
- Low
- 0.34% (15 Jul 2024)
- Average
- 0.67%
- Highest days to cover
- 1.94 (15 Feb 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 0.62% | 1.17 | |
| 15 Feb 2024 | 0.42% | 1.94 | |
| 15 Mar 2024 | 1.32% | 1.00 | |
| 28 Mar 2024 | 0.98% | 1.00 | 10-K filed, results (8-K) |
| 15 Apr 2024 | 0.86% | 1.00 | |
| 30 Apr 2024 | 0.53% | 1.35 | |
| 15 May 2024 | 0.46% | 1.29 | 10-Q filed, results (8-K) |
| 31 May 2024 | 0.36% | 1.53 | |
| 14 Jun 2024 | 0.50% | 1.00 | |
| 28 Jun 2024 | 0.47% | 1.00 | |
| 15 Jul 2024 | 0.34% | 1.00 | |
| 31 Jul 2024 | 0.51% | 1.78 | |
| 31 Oct 2024 | 1.36% | 1.00 | 10-Q filed, results (8-K) |
| 31 Dec 2024 | 0.69% | 1.00 | 10-Q filed, results (8-K) |
See also: Monopar Therapeutics's full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.